Search

Obtenga más información sobre el primer centro en el mundo dedicado a las necesidades específicas de los pacientes con cáncer colorrectal menores de 50 años.

… Monday, March 8, 2021 Resumen Un aumento preocupante de casos de cáncer colorrectal entre los adultos más jóvenes ha llevado a los expertos a sugerir que se publiquen nuevas pautas que reduzcan la edad recomendada en que las personas deben comenzar a hacerse las pruebas de detección colorrectal de los

Local control rates and overall survival (OS) were significantly higher for patients with brain metastases treated with adjuvant stereotactic radiosurgery (SRS) within two months of resection, compared to longer time intervals, according to our new study published recently in Neuro-Oncology Practice.

… Thursday, September 23, 2021 Local control rates and overall survival (OS) were significantly higher for patients with brain metastases treated with adjuvant stereotactic radiosurgery (SRS) within two months of resection, compared to longer time intervals, according to our new study published recently

A landmark study led in part by physician-researchers from Memorial Sloan Kettering is giving new hope to some people with metastatic colorectal cancer.

… Wednesday, December 23, 2020 A landmark study led in part by physician-researchers from Memorial Sloan Kettering is giving new hope to some people with metastatic colorectal cancer. In a recent issue of the  New England Journal of Medicine , results from the phase III study — Keynote 177 — provided further

一项由纪念斯隆凯特琳的医生-研究人员部分主导的具有里程碑意义的研究给部分转移性结直肠癌患者带来新的希望。

… Wednesday, December 23, 2020 一项由纪念斯隆凯特琳的医生-研究人员部分主导的具有里程碑意义的研究给部分转移性结直肠癌患者带来新的希望。 在最近一期的 《新英格兰医学杂志》 上，III 期研究 (Keynote 177) 的结果提供了进一步相关证据，证明当用作一线治疗时， 免疫治疗 药物帕博利珠单抗 可改善不可切除及微卫星不稳定性-高 (MSI-H) /错配修复缺陷 (dMMR) 转移性结直肠癌患者的疾病进展。 今年 6 月，帕博利珠单抗获得 FDA 突破性疗法的认定 ，用于该亚组患者的治疗。 大约 5% 的转移性结直肠癌患者患有 MSI-H/dMMR 类型的疾病。 在癌症中

The Starr Foundation is continuing its longstanding commitment to stem cell research in New York City with a $50 million gift in support of the Tri-Institutional Stem Cell Initiative (Tri-SCI), a research collaboration between Memorial Sloan Kettering Cancer Center, The Rockefeller University and Weill Cornell Medicine.

… Thursday, April 4, 2019 The Starr Foundation is continuing its longstanding commitment to stem cell research in New York City with a $50 million gift in support of the Tri-Institutional Stem Cell Initiative (Tri-SCI), a research collaboration between Memorial Sloan Kettering Cancer Center, The Rockefeller

Learn more about how a clinical trial at MSK revealed important connections between the foods we eat and our cancer risk.

… Monday, December 8, 2025 If you or a loved one is facing cancer, you may wish you could regain some sense of control when so much feels beyond your power. You may wonder what you can or should eat. Comfort food? Healthy food? How much does it matter? The effort at Memorial Sloan Kettering Cancer Center

There is a significant threat to pediatric cancer research stemming from COVID-19's impact on philanthropy. That message is shared by MSK’s Chair of the Department of Pediatrics, Andrew Kung, MD, PhD, in a recent op-ed published in U.S. News & World Report.

… Thursday, October 1, 2020 There is a significant threat to pediatric cancer research stemming from COVID-19’s impact on philanthropy. That message is shared by MSK’s Chair of the Department of Pediatrics, Andrew Kung, MD, PhD , in a recent op-ed published in U.S. News & World Report . Dr. Kung points

To mark National Colorectal Awareness Month this March, MSK stressed the importance of resuming vital screenings for colorectal cancer amid the COVID-19 pandemic.

… Wednesday, March 3, 2021 To mark National Colorectal Awareness Month this March, Memorial Sloan Kettering Cancer Center (MSK) today stressed the importance of resuming vital screenings for colorectal cancer .  The American Cancer Society (ACS) has recommended colorectal cancer screenings begin at age

One size does not fit all when it comes to treating renal cell carcinoma.

… Tuesday, January 15, 2019 Summary Scientists at Memorial Sloan Kettering have identified factors in a tumor’s environment that predict how well it will respond to certain cancer therapies. If cancer is like a weed that sprouts from a seed, then the tumor microenvironment is like the soil that nurtures

Cancer screenings are essential. MSK’s Physician-In-Chief and Chief Medical Officer, Lisa DeAngelis, MD, shared why cancer care screenings are critical during an interview with PBS Metrofocus.

… Friday, August 14, 2020 It’s time to go back. Cancer care is essential care and screenings and treatments can’t wait. That was the message that MSK’s Physician-In-Chief and Chief Medical Officer, Lisa DeAngelis, MD, shared during a recent interview with  PBS Metrofocus .  When COVD-19 first hit the tri-state